NousCom presents at EMBL-Cancer Core Europe Conference: Cancer Immunotherapy

EMBL Heidelberg, Germany

Abstract Title: Personalized cancer vaccine based on ChAd vaccine improves over the anti-PD1 activity.

Recent Posts